Dosing and Misuse of Buprenorphine in the New Jersey Department of Corrections

Article Figures & Data

Table 1

Dosing, Changes in Dosing, and Clinical Characteristics

	Misuse Possible	Misuse Specified	Misuse: BNX	Misuse: BUP	No Misuse	No Misuse: BNX	No Misuse: BUP
n	161	103	78	25	134	121	13
Mean dose (mg)	9.50	9.48	9.23	10.24	9.18	9.16	9.38
Multiple strips or tabs? (%)	35 (21.7%)^{^a}	27 (26.2%)^{^b}	7 (9.0%)^{^c}	20 (80.0%)^{^c}	17 (12.7%)^{^a,^b}	0 (0%)^{^d}	9 (69.2%)^{^d}
Change? (%)	53 (32.9%)	46 (44.7%)	34 (43.6%)	12 (48.0%)	22 (16.4%)	17 (14.0%)	6 (46.2%)
Increase? (%)	12 (7.5%)	6 (5.8%)	6 (7.7%)	0 (0%)^{^b}	13 (9.7%)	9 (7.4%)	4 (30.8%)^{^b}
Decrease? (%)	41 (25.5%)^{^c}	40 (38.8%)	28 (35.9%)	12 (48.0%)	9 (6.7%)^{^c}	8 (6.6%)	2 (15.4%)
SNR? (%)	100 (74.6%)	69 (67.0%)^{^a}	57 (73.1%)^{^e}	12 (48.0%)	67 (50%)^{^a}	62 (51.2%)^{^e}	5 (38.5%)
ASPD (%)	45 (33.6%)	33 (32.0%)	27 (34.6%)^{^f}	6 (24.0%)	26 (19.4%)	23 (19.0%)^{^f}	3 (23.1%)

↵a p < .05.
↵b p = .01.
↵c p < .001.
↵d p = .001.
↵e p = .003.
↵f p = .02.
Abbreviations: ASPD = antisocial personality disorder; BNX = buprenorphine-naloxone strips; BUP = buprenorphine tabs; misuse possible = prescribed a buprenorphine product at the time of the misuse of medication charge; misuse specified = both prescribed a buprenorphine product and clinical documentation supports misuse at the time of the misuse of medication charge; SNR = special needs roster.

Table 2

Medications Most Often Coprescribed with Buprenorphine Products